<?xml version='1.0'?>
<!DOCTYPE art SYSTEM 'http://www.biomedcentral.com/xml/article.dtd'>
<art>
	<ui>cc4831</ui>
	<ji>CCJ</ji>
	<fm>
		<dochead>Review</dochead>
		<bibl>
			<title>
				<p>Oxygen uptake-to-delivery relationship: a way to assess adequate flow</p>
			</title>
			<aug>
				<au id="A1">
					<snm>Caille</snm>
					<fnm>Vincent</fnm>
					<insr iid="I1"/>
				</au>
				<au id="A2" ca="yes">
					<snm>Squara</snm>
					<fnm>Pierre</fnm>
					<insr iid="I2"/>
					<email>pierre.squara@wanadoo.fr</email>
				</au>
			</aug>
			<insg>
				<ins id="I1">
					<p>Service de Chirurgie Cardio-vasculaire, H&#244;pital Foch, Suresnes, France</p>
				</ins>
				<ins id="I2">
					<p>Ceric, Clinique Ambroise Pare, Neuilly-Sur-Seine, France</p>
				</ins>
			</insg>
			<source>Critical Care</source>
			<supplement>
				<title>
					<p>A reappraisal for the use of pulmonary artery catheters</p>
				</title>
				<editor>Beno&#238;t Vallet</editor>
				<sponsor>
					<note>Publication of this supplement has been supported by an educational grant from Edwards Lifesciences.</note>
				</sponsor>
				<note>Reviews</note>
			</supplement>
			<issn>1364-8535</issn>
			<pubdate>2006</pubdate>
			<volume>10</volume>
			<issue>Suppl 3</issue>
			<fpage>S4</fpage>
			<url>http://ccforum.com/content/10/S3/S4</url>
			<xrefbib>
				<pubidlist><pubid idtype="pmpid">17164016</pubid><pubid idtype="doi">10.1186/cc4831</pubid>
				</pubidlist></xrefbib>
		</bibl>
		<history>
			<pub>
				<date>
					<day>27</day>
					<month>11</month>
					<year>2006</year>
				</date>
			</pub>
		</history>
		<cpyrt>
			<year>2006</year>
			<collab>BioMed Central Ltd</collab>
		</cpyrt>
		<abs>
			<sec>
				<st>
					<p>Abstract</p>
				</st>
				<p>Invasive and noninvasive monitoring facilitates clinical evaluation when resuscitating patients with complex haemodynamic disorders. If the macrocirculation is to be stable, then it must adapt to blood flow or blood flow must be optimized. The objective of flow monitoring is to assist with matching observed oxygen consumption (VO<sub>2</sub>) to pathophysiological needs. If an adequate balance cannot be maintained then dysoxia occurs. In this review we propose a simple schema for global reasoning; we discuss the limitations of VO<sub>2 </sub>and arterial oxygen delivery (DaO<sub>2</sub>) assessment; and we address concerns about increasing DaO<sub>2 </sub>to supranormal values or targeting pre-established levels of DaO<sub>2</sub>, cardiac output, or mixed venous oxygen saturation. All of these haemodynamic variables are interrelated and limited by physiological and/or pathological processes. A unique global challenge, and one that is of great prognostic interest, is to achieve rapid matching between observed and needed VO<sub>2 </sub>&#8211; no more and no less. However, measuring or calculating these two variables at the bedside remains difficult. In practice, we propose a distinction between three situations. Clinical and blood lactate clearance improvements can limit investigations in simple cases. Intermediate cases may be managed by continuous monitoring of VO<sub>2</sub>-related variables such as DaO<sub>2</sub>, cardiac output, or mixed venous oxygen saturation. In more complex cases, three methods can help to estimate the needed VO<sub>2 </sub>level: comparison with expected values from past physiological studies; analysis of the relationship between VO<sub>2 </sub>and oxygen delivery; and use of computer software to integrate the preceding two methods.</p>
			</sec>
		</abs>
	</fm>
	<bdy>
		<sec>
			<st>
				<p>Introduction</p>
			</st>
			<p>Major advances have been made in monitoring the critically ill patient following the introduction in the 1970s of intravascular pressure and flow recording catheters <abbrgrp><abbr bid="B1">1</abbr></abbrgrp>. Today, flow monitoring is one of the major reasons to admit patients into an intensive care unit (ICU), but which of the flow-based parameters are really interesting from a clinical perspective?</p>
			<p>A reasonable assumption is that below a critical level the oxygen consumption (VO<sub>2</sub>) is inversely related to the risk for cell dysfunction and necrosis and to the severity of shock. Among the various haemodynamic variables that may be evaluated, a VO<sub>2 </sub>below the required level is most strongly related to death <abbrgrp><abbr bid="B2">2</abbr></abbrgrp>. Once a substantial amount of cell necrosis has occurred, organ function recovery is not always possible, even when adequate VO<sub>2 </sub>is restored. Thus, it is intuitive that flow monitoring must be aimed at early adaptation of VO<sub>2 </sub>to metabolic needs <abbrgrp><abbr bid="B3">3</abbr><abbr bid="B4">4</abbr></abbrgrp>. Although this is universally accepted, its usefulness at the bedside has been challenged because of theoretical and practical limitations of VO<sub>2 </sub>assessment <abbrgrp><abbr bid="B5">5</abbr><abbr bid="B6">6</abbr></abbrgrp>. However, it has been shown that several of these limitations have been over-stated <abbrgrp><abbr bid="B4">4</abbr></abbrgrp>. In addition, targeting a VO<sub>2 </sub>that is adequate to meet the patient's needs does not necessarily require continuous VO<sub>2 </sub>measurement. Monitoring VO<sub>2</sub>-related variables such as cardiac output (CO) and/or mixed venous oxygen saturation (SvO<sub>2</sub>) may represent an acceptable compromise, especially as these variables can be obtained less invasively.</p>
			<p>This review proposes a simple and comprehensive schema for understanding and adapting flow monitoring in order to stabilize the macrocirculation.</p>
		</sec>
		<sec>
			<st>
				<p>Fundamental basis of the relationship between oxygen consumption and delivery</p>
			</st>
			<p>For each cell, life requires enough energy for metabolic activity. Energy depends on oxidative reactions that require nutrients and oxygen. For each cell most of the oxygen is used for oxidative mechanisms. Nonoxidative systems have lower affinity for oxygen than do cytochrome oxidase systems. Therefore, significant activity of the non-mitochondrial oxidase systems can only be present when there is no more dysoxia.</p>
			<p>Hence, for each cell a match between VO<sub>2 </sub>and needed VO<sub>2 </sub>(<sup>n</sup>VO<sub>2</sub>) is necessary for life. This basic relationship between life and energy is also applicable to each organ and to the body as a whole. However, a whole body VO<sub>2 </sub>that equals body needs does not guarantee that circulation is adequate for each cell because distributive mismatch may lead to nonoxidative metabolism in some areas and dysoxia in others. However, it is a prerequisite that the macrocirculation must be stabilized before one may examine the microcirculation. Consequently, the first priority is to consider the balance between whole body VO<sub>2 </sub>and <sup>n</sup>VO<sub>2</sub>.</p>
			<p>For all systems, VO<sub>2 </sub>is the difference between the input flow and the output flow. For the whole body circulation, the input flow is the arterial oxygen delivery (DaO<sub>2</sub>) and the output flow is the venous oxygen delivery. If one considers the oxygen extraction ratio (EO<sub>2</sub>) to be the ratio between VO<sub>2 </sub>and DaO<sub>2</sub>, then VO<sub>2 </sub>can be represented by the product DaO<sub>2 </sub>&#215; EO<sub>2</sub>. The simple equation VO<sub>2 </sub>= DaO<sub>2 </sub>&#215; EO<sub>2 </sub>is conventionally used to represent the macrocirculatory balance.</p>
			<p>The VO<sub>2 </sub>observed (<sup>o</sup>VO<sub>2</sub>) by a clinician (either measured or calculated) is the product of an observed DO<sub>2 </sub>and an observed EO<sub>2</sub>, such that <sup>o</sup>VO<sub>2 </sub>= <sup>o</sup>DO<sub>2 </sub>&#215; <sup>o</sup>EO<sub>2</sub>. Similarly, the specific patient's requirements (<sup>n</sup>VO<sub>2</sub>) may be formulated as the product of the needed DO<sub>2 </sub>and the needed EO<sub>2</sub>: <sup>n</sup>VO<sub>2 </sub>= <sup>n</sup>DO<sub>2 </sub>&#215; <sup>n</sup>EO<sub>2</sub>. The ratio between these two equations represents the balance between what the doctor sees and what the patient needs: <sup>o</sup>VO<sub>2</sub>/<sup>n</sup>VO<sub>2 </sub>= <sup>o</sup>DO<sub>2</sub>/<sup>n</sup>DO<sub>2 </sub>&#215; <sup>o</sup>EO<sub>2</sub>/<sup>n</sup>EO<sub>2</sub>. Any change in <sup>o</sup>DO<sub>2</sub>/<sup>n</sup>DO<sub>2 </sub>must be balanced by an inverse change in <sup>o</sup>EO<sub>2</sub>/<sup>n</sup>EO<sub>2 </sub>to maintain <sup>o</sup>VO<sub>2</sub>/<sup>n</sup>VO<sub>2 </sub>= 1 and <it>vice versa</it>. 
When <sup>o</sup>VO<sub>2</sub>/<sup>n</sup>VO<sub>2 </sub>= 1 cannot be maintained, dysoxia occurs. Consequently, three indices of performance may be described: <sup>o</sup>VO<sub>2</sub>/<sup>n</sup>VO<sub>2 </sub>is an index of global performance, with a value below 1 indicating shock; <sup>o</sup>DO<sub>2</sub>/<sup>n</sup>DO<sub>2 </sub>is an index of circulatory performance, with a value below 1 indicating circulatory failure; and <sup>o</sup>EO<sub>2</sub>/<sup>n</sup>EO<sub>2 </sub>is an index of tissue performance, with a value below 1 indicating tissue failure.</p>
			<p>We do not propose that these indices be calculated for each and every patient, but they should perhaps be borne in mind to facilitate, at any time, empirical review of the patient's likely status and to determine the probable results of any therapeutic intervention.</p>
		</sec>
		<sec>
			<st>
				<p>Clinical means to deal with concepts</p>
			</st>
			<p>Evaluation of whether macrocirculatory adaptation is adequate requires one to answer several simple questions.</p>
			<sec>
				<st>
					<p>Is oxygen consumption equal to the patient's needs?</p>
				</st>
				<p>Otherwise stated, is the expression <sup>o</sup>VO<sub>2</sub>/<sup>n</sup>VO<sub>2 </sub>= 1 true? Three levels of complexity may be defined.</p>
				<p>First, clinical improvement is a good indicator of adequate resuscitation <abbrgrp><abbr bid="B7">7</abbr></abbrgrp>. In practice, the <sup>n</sup>VO<sub>2 </sub>is usually met by decreasing metabolic requirement, optimizing the haematocrit and arterial haemoglobin oxygen saturation, and increasing blood flow empirically until the clinical status improves. This situation does not require invasive haemodynamic investigation.</p>
				<p>Second, a clear improvement in blood lactate clearance is also a good and minimally invasive indicator of adequate resuscitation <abbrgrp><abbr bid="B7">7</abbr></abbrgrp>. The blood lactate concentration alone fails to discriminate between dysoxia and aerobiosis <abbrgrp><abbr bid="B8">8</abbr></abbrgrp>. Although more reliable, the time course of lactate levels is not an ideal marker <abbrgrp><abbr bid="B2">2</abbr><abbr bid="B7">7</abbr><abbr bid="B9">9</abbr></abbrgrp>. The limitations of lactate were recently reviewed <abbrgrp><abbr bid="B8">8</abbr></abbrgrp>. Diabetes mellitus, liver dysfunction, tissue reperfusion, catecholamine infusion, cellular metabolic alterations and inhibition of pyruvate dehydrogenase can all result in a marked increase in blood lactate concentrations, despite improvement in tissue dysoxia.</p>
				<p>Finally, in more complex situations in which clear clinical improvement and normalization in blood lactate are not observed, evaluation of oxygenation is required, followed by an evaluation of <sup>o</sup>VO<sub>2 </sub>and <sup>n</sup>VO<sub>2</sub>. The <sup>o</sup>VO<sub>2 </sub>can be measured at the bedside using expired gases <abbrgrp><abbr bid="B10">10</abbr></abbrgrp> or it may be calculated from the product of CO and the arteriovenous difference in blood oxygen content. Demonstrating that <sup>o</sup>VO<sub>2</sub>/<sup>n</sup>VO<sub>2 </sub>= 1 requires one to evaluate <sup>n</sup>VO<sub>2 </sub>concomitantly. When <sup>o</sup>VO<sub>2 </sub>is evaluated alone, this provides no information of prognostic interest <abbrgrp><abbr bid="B2">2</abbr></abbrgrp>.</p>
			</sec>
			<sec>
				<st>
					<p>How may we estimate the needed oxygen consumption?</p>
				</st>
				<p>Needs can initially be estimated as the sum of VO<sub>2 </sub>at basal metabolism, as indicated by age-specific and sex-specific normative data, and the additional VO<sub>2 </sub>that results from other metabolic requirements. The latter can be approximated based on a number of factors, such as body temperature (<sup>n</sup>VO<sub>2 </sub>changes by &#177; 13% for each 1&#176;C above or below 37&#176;C). Pathologic situations such as respiratory failure and severe sepsis also increase metabolic needs. Based on metabolic conditions, <sup>n</sup>VO<sub>2 </sub>can vary from 0.7-fold to 3-fold the basal metabolism.</p>
				<p>Needs can also be estimated by using the specific VO<sub>2</sub>/DO<sub>2 </sub>relationship (Figure <figr fid="F1">1</figr>). A biphasic relationship between oxygen use and resources has been established <abbrgrp><abbr bid="B6">6</abbr></abbrgrp>. When DO<sub>2 </sub>is greater than a threshold value, VO<sub>2 </sub>remains stable (oxygen supply independency) because the EO<sub>2 </sub>changes proportionally. When DO<sub>2 </sub>falls below this threshold, a proportionate increase in EO<sub>2 </sub>cannot be maintained and the VO<sub>2 </sub>drops linearly to zero (oxygen supply dependency). There is consensus that the inflection point between the two slopes indicates the critical level of DO<sub>2 </sub>(Figure <figr fid="F1">1</figr>). Oxygen supply dependency is associated with increased blood lactate concentration, denoting possible activation of the anaerobic pathway.</p>
				<fig id="F1">
					<title>
						<p>Figure 1</p>
					</title>
					<caption>
						<p>Pathophysiological changes in the VO<sub>2</sub>/DO<sub>2 </sub>relationship</p>
					</caption>
					<text>
						<p>Pathophysiological changes in the VO<sub>2</sub>/DO<sub>2 </sub>relationship. Normal relationship is shown in a solid black line, and abnormal relationships in dotted lines. 1: Increased VO<sub>2 </sub>needs; 2: impaired EO<sub>2</sub>; 3: other mechanisms (see text). The grey curves are the corresponding EO<sub>2</sub>/DO<sub>2 </sub>relationships. DO<sub>2</sub>, oxygen delivery; EO<sub>2</sub>, oxygen extraction ratio; VO<sub>2</sub>, oxygen consumption. Reproduced with permission from Squara [4].</p>
					</text>
					<graphic file="cc4831-1"/>
				</fig>
				<p>Assessment of the VO<sub>2</sub>/DO<sub>2 </sub>relationship is a theoretical means to evaluate the gap between actual VO<sub>2 </sub>and <sup>n</sup>VO<sub>2</sub>. When DO<sub>2 </sub>increases, an increase in VO<sub>2 </sub>suggests that oxygen supply is inadequate. In contrast, a stable VO<sub>2 </sub>value when DO<sub>2 </sub>increases suggests either that VO<sub>2 </sub>matches needs when it is associated with decreasing lactate levels <abbrgrp><abbr bid="B11">11</abbr><abbr bid="B12">12</abbr></abbrgrp> or that VO<sub>2 </sub>is limited by mechanisms other than oxygen supply when it is associated with increasing lactate levels <abbrgrp><abbr bid="B13">13</abbr><abbr bid="B14">14</abbr></abbrgrp>.</p>
				<p>In pathophysiology, two mechanisms delay achievement of the VO<sub>2 </sub>plateau and account for a rightward shift in the critical DO<sub>2 </sub>point (Figure <figr fid="F1">1</figr>). When VO<sub>2 </sub>needs are excessive (uncoupling and/or increased metabolic activity), the VO<sub>2 </sub>plateau is reached at a higher level of VO<sub>2 </sub><abbrgrp><abbr bid="B15">15</abbr><abbr bid="B16">16</abbr></abbrgrp>. When oxygen tissue diffusion is impaired (impaired microcirculation and/or impaired oxygen mitochondrial use), the slope of the dependant part of the VO<sub>2</sub>/DO<sub>2 </sub>relationship is decreased <abbrgrp><abbr bid="B17">17</abbr><abbr bid="B18">18</abbr></abbrgrp>.</p>
				<p>Three other mechanisms result in an increase in VO<sub>2 </sub>as DO<sub>2 </sub>increases beyond the critical point, so that a slight upward slope &#8211; usually of less than 5% &#8211; replaces the expected VO<sub>2 </sub>plateau. Although more difficult, identification of the critical DO<sub>2 </sub>inflection point remains possible when these mechanisms are operative because the slope of the VO<sub>2</sub>/DO<sub>2 </sub>dependency segment ranges from 20% to 50% <abbrgrp><abbr bid="B19">19</abbr></abbrgrp>. The first mechanism occurs during a DO<sub>2 </sub>challenge involving an increase in CO, because the VO<sub>2 </sub>needs of kidneys <abbrgrp><abbr bid="B20">20</abbr></abbrgrp>, stomach <abbrgrp><abbr bid="B21">21</abbr></abbrgrp> and muscle <abbrgrp><abbr bid="B22">22</abbr></abbrgrp> increase in direct proportion to flow. Furthermore, infusion of inotropic agents increases myocardial oxygen consumption <abbrgrp><abbr bid="B11">11</abbr><abbr bid="B12">12</abbr><abbr bid="B19">19</abbr></abbrgrp>. Another mechanism is additional oxygen uptake due to non-mitochondrial oxidase systems when dysoxia has resolved <abbrgrp><abbr bid="B23">23</abbr></abbrgrp>. The final mechanism, termed conformance, is a decrease in the metabolic needs of cells that occurs in response to a gradual decline in available oxygen. Although secondary to a chronic change, this phenomenon has been observed in acute situations <abbrgrp><abbr bid="B24">24</abbr></abbrgrp>. Schumacker and coworkers <abbrgrp><abbr bid="B25">25</abbr></abbrgrp> reported that a VO<sub>2 </sub>increase occurred in unshocked patients after aortic stenosis valvuloplasty.</p>
				<p>A controversy arose during the late 1980s from several studies on acute respiratory distress syndrome and/or sepsis, in which the expected VO<sub>2 </sub>plateau was not observed in patients who were recovering from shock and had high DO<sub>2 </sub>values <abbrgrp><abbr bid="B26">26</abbr><abbr bid="B27">27</abbr></abbrgrp>. This was interpreted as evidence of 'pathologic oxygen supply dependency', possibly related to hidden oxygen deficit and contributing to multiorgan failure and death. However, increasing DO<sub>2 </sub>to supranormal values was beneficial in some studies <abbrgrp><abbr bid="B28">28</abbr><abbr bid="B29">29</abbr></abbrgrp> but not in others <abbrgrp><abbr bid="B30">30</abbr><abbr bid="B31">31</abbr></abbrgrp>. Furthermore, it has been suggested this so-called 'pathologic supply dependency' may result from spurious up-sloping of the VO<sub>2</sub>/DO<sub>2 </sub>relationship due to mathematical coupling of measurement errors when using a pulmonary artery catheter (PAC), because in some studies simultaneous independent VO<sub>2 </sub>assessment revealed a plateau <abbrgrp><abbr bid="B5">5</abbr><abbr bid="B6">6</abbr><abbr bid="B32">32</abbr></abbrgrp>. In addition, VO<sub>2 </sub>and DO<sub>2 </sub>assessment are limited by theoretical and practical concerns <abbrgrp><abbr bid="B5">5</abbr><abbr bid="B6">6</abbr></abbrgrp>. However, these limitations were recently reviewed <abbrgrp><abbr bid="B4">4</abbr></abbrgrp>. Use of the most recent generation of devices for continuous CO monitoring and blood gas analysis minimizes the variability in measurement. It has been proposed that the relevance of the VO<sub>2</sub>/DO<sub>2 </sub>relationship could be increased by combined analysis of the VO<sub>2</sub>/time relationship (Figure <figr fid="F2">2</figr>) <abbrgrp><abbr bid="B4">4</abbr></abbrgrp>. Thus, although difficult, acceptable identification of the VO<sub>2 </sub>plateau, and of the <sup>n</sup>VO<sub>2</sub>, is possible when necessary.</p>
				<fig id="F2">
					<title>
						<p>Figure 2</p>
					</title>
					<caption>
						<p>Comparison between the VO<sub>2</sub>/DO<sub>2 </sub>relationship and the VO<sub>2</sub>/time relationship in one hypothetical example</p>
					</caption>
					<text>
						<p>Comparison between the VO<sub>2</sub>/DO<sub>2 </sub>relationship and the VO<sub>2</sub>/time relationship in one hypothetical example. For this figure, DO<sub>2 </sub>increased linearly with time. This helps to identify the critical VO<sub>2 </sub>point and eliminates the possible effect of mathematical coupling of error. DO<sub>2</sub>, oxygen delivery; VO<sub>2</sub>, oxygen consumption. Reproduced with permission from Squara [4].</p>
					</text>
					<graphic file="cc4831-2"/>
				</fig>
				<p>Finally, it may be concluded that <sup>o</sup>VO<sub>2 </sub>= <sup>n</sup>VO<sub>2 </sub>when one or several of the following factors is present: clinical improvement, decrease in blood lactate concentration, and <sup>o</sup>VO<sub>2 </sub>inside the expected range and/or inflexion point in the <sup>o</sup>VO<sub>2</sub>/DO<sub>2 </sub>curve. The two methods can be combined. When the <sup>o</sup>VO<sub>2 </sub>plateau is reached at a value close to the estimated needs, the patient's real needs are probably met. Handling the large amount of information required to assess oxygen needs can be difficult <abbrgrp><abbr bid="B33">33</abbr><abbr bid="B34">34</abbr></abbrgrp>, and computer assistance may be helpful <abbrgrp><abbr bid="B2">2</abbr><abbr bid="B35">35</abbr><abbr bid="B36">36</abbr></abbrgrp>.</p>
			</sec>
		</sec>
		<sec>
			<st>
				<p>Are there other means to balance oxygen consumption and needs?</p>
			</st>
			<sec>
				<st>
					<p>Supraphysiologic targets</p>
				</st>
				<p>Some investigators have recommended that DO<sub>2 </sub>be increased to supranormal values, greater than the usual critical level, without paying much attention to VO<sub>2</sub>. This simplification of the method based on the VO<sub>2</sub>/DO<sub>2 </sub>relationship was associated with favourable outcomes in homogeneous populations of patients undergoing high-risk surgery <abbrgrp><abbr bid="B37">37</abbr><abbr bid="B38">38</abbr></abbrgrp>, with cardiogenic shock following myocardial infarction <abbrgrp><abbr bid="B39">39</abbr></abbrgrp> and with acute respiratory failure <abbrgrp><abbr bid="B15">15</abbr><abbr bid="B40">40</abbr></abbrgrp>. However, those studies failed to demonstrate any beneficial effects after the onset of organ failure <abbrgrp><abbr bid="B38">38</abbr></abbrgrp> or when different aetiologies of shock were pooled together <abbrgrp><abbr bid="B15">15</abbr><abbr bid="B40">40</abbr></abbrgrp>.</p>
			</sec>
			<sec>
				<st>
					<p>Monitoring of cardiac output and mixed venous oxygen saturation</p>
				</st>
				<p>Other studies suggest that sequential DO<sub>2 </sub>and VO<sub>2 </sub>calculations can be advantageously replaced by continuous measurement of CO <abbrgrp><abbr bid="B41">41</abbr></abbrgrp>, SvO<sub>2 </sub><abbrgrp><abbr bid="B42">42</abbr></abbrgrp>, or central venous oxygen saturation <abbrgrp><abbr bid="B43">43</abbr></abbrgrp>. The use of these variables avoids compounding of measurement errors and allows for continuous comparison between measured values and targeted values.</p>
				<p>However, targeting a pre-established value for DO<sub>2</sub>, CO, or SvO<sub>2 </sub>does not prove that these values meet the needs of an individual patient <abbrgrp><abbr bid="B16">16</abbr></abbrgrp>. These pre-established targets are derived from normal findings or from survivors in selected populations of patients <abbrgrp><abbr bid="B44">44</abbr><abbr bid="B45">45</abbr></abbrgrp>. Determination of the needed value of one given variable must take into consideration the limitation in other variables that are specific to the patient, his past history, the actual pathologic event, the delay before onset of shock and often recent therapeutic interventions (Figure <figr fid="F3">3</figr>). Intuitive evaluation of the needed value of each variable in each specific case requires considerable expertise. Misinterpretation of information derived from PAC placement and heterogeneity in the medical decision process is frequent <abbrgrp><abbr bid="B30">30</abbr><abbr bid="B31">31</abbr></abbrgrp>. Even for experts, intuitive evaluation of needs may be subject to errors <abbrgrp><abbr bid="B16">16</abbr></abbrgrp>. In some conditions, such as coronary disease, efforts to increase CO in order to 'normalize' the cardiac index to more than 2.5 l/min per m<sup>2 </sup>or the SvO<sub>2 </sub>value to more than 70% can be harmful (see examples given below). In addition, there is some evidence that an excessive oxygen supply may be deleterious, either via the useless metabolic cost of an excessive increase in DO<sub>2 </sub>or via activation of nonoxidative systems. Failure to consider these latter two mechanisms may also account for the poor results obtained in controlled studies targeting nonspecific 'supranormal' values of DO<sub>2 </sub><abbrgrp><abbr bid="B30">30</abbr><abbr bid="B31">31</abbr></abbrgrp>. Thus, treatment efforts should be limited to what is necessary &#8211; no less and no more.</p>
				<fig id="F3">
					<title>
						<p>Figure 3</p>
					</title>
					<caption>
						<p>Nomogram showing CI, SvO<sub>2 </sub>and VO<sub>2 </sub>isopleths (dotted black lines)</p>
					</caption>
					<text>
						<p>Nomogram showing CI, SvO<sub>2 </sub>and VO<sub>2 </sub>isopleths (dotted black lines). The green point shows the expected values for a 59-year-old woman at basal metabolism, and the green dotted arrow indicates the expected normal variations in case of hypo- or hypermetabolism. The real position of the patient in the nomogram can be continuously monitored. This is adequate for diagnostic purposes. The patient's position can move from the normal profile to a characterized area of septic or cardiogenic shock (grey dotted arrows and areas). However, for therapeutic objectives, this nomogram gives no idea of needs. If we made the hypothesis that the <sup>n</sup>VO<sub>2 </sub>(red isopleth) is higher than the <sup>o</sup>VO<sub>2</sub>, then the red double arrow indicates the difference between <sup>n</sup>VO<sub>2 </sub>and <sup>o</sup>VO<sub>2</sub>. Units for CI are l/min per m<sup>2 </sup>and for VO<sub>2 </sub>they are ml/min per m<sup>2</sup>. CI, cardiac index; <sup>(n/o)</sup>VO<sub>2</sub>, (needed/observed) oxygen consumption; SvO<sub>2</sub>, mixed venous oxygen saturation.</p>
					</text>
					<graphic file="cc4831-3"/>
				</fig>
			</sec>
			<sec>
				<st>
					<p>The relationship between cardiac output and mixed venous oxygen saturation</p>
				</st>
				<p>All haemodynamic variables are interrelated, and ensuring that VO<sub>2 </sub>meets needs is the best tool to ensure that global haemodynamic status is adequate. VO<sub>2</sub>, whether calculated by spirometry, indirect calorimetry, or using a PAC, is similar to the plateau of VO<sub>2 </sub>in the VO<sub>2</sub>/DO<sub>2 </sub>relationship. No other relationship between two variables allows a clear identification of a plateau or a clear inflection point between anaerobiosis and aerobiosis. The shape of the CO/SvO<sub>2 </sub>relationship or the CO/EO<sub>2 </sub>relationship is bi-curvilinear and similar to the DO<sub>2</sub>/EO<sub>2 </sub>relationship shown in Figure <figr fid="F1">1</figr>. A clear inflexion point between aerobiosis and anaerobiosis is much more difficult to identify than the VO<sub>2</sub>/DO<sub>2</sub>.</p>
			</sec>
		</sec>
		<sec>
			<st>
				<p>Clinical examples</p>
			</st>
			<sec>
				<st>
					<p>Example 1</p>
				</st>
				<p>Patient 1, receiving sedative drugs and mechanical ventilation, was admitted to an ICU immediately after an aortic valve replacement. He was hypothermic, with marbled and cold extremities. Haemodynamic variables are listed in Table <tblr tid="T1">1</tblr>. In this patient, cold extremities may be due to hypothermia, and the supranormal serum lactate may result from postoperative washout. Therefore, clinical evaluation including lactate level is not relevant in evaluating macrocirculatory performance relative to metabolic needs. Other means to explore the balance between VO<sub>2 </sub>and needs are conflicting. The SvO<sub>2 </sub>(65%) was below the expected value and may be considered a marker of unacceptably low CO and oxygen flow <abbrgrp><abbr bid="B45">45</abbr><abbr bid="B46">46</abbr></abbrgrp>. In contrast the calculated <sup>o</sup>VO<sub>2 </sub>(88 ml/min per m<sup>2</sup>) is close to expected <sup>n</sup>VO<sub>2 </sub>(90 ml/min per m<sup>2</sup>) when assessed using the basal VO<sub>2 </sub>value for this 82-year-old man (119 ml/min per m<sup>2</sup>, as indicated by age-specific and sex-specific normative data), corrected according to the low body temperature. It would be difficult to exploit the VO<sub>2</sub>/DO<sub>2 </sub>relationship. No VO<sub>2 </sub>plateau is expected in the early postoperative period because of increasing metabolic needs.</p>
				<tbl id="T1">
					<title>
						<p>Table 1</p>
					</title>
					<caption>
						<p>Clinical parameters of two patients admitted to the ICU (sedative infusions and mechanical ventilation required)</p>
					</caption>
					<tblbdy cols="6">
						<r>
							<c>
								<p/>
							</c>
							<c cspan="2" ca="center">
								<p>Patient 1 (male, 84 years)</p>
							</c>
							<c cspan="3" ca="center">
								<p>Patient 2 (male, 24 years)</p>
							</c>
						</r>
						<r>
							<c>
								<p/>
							</c>
							<c cspan="2">
								<hr/>
							</c>
							<c cspan="3">
								<hr/>
							</c>
						</r>
						<r>
							<c ca="left">
								<p>Parameters</p>
							</c>
							<c ca="center">
								<p>H<sub>0</sub></p>
							</c>
							<c ca="center">
								<p>H<sub>2</sub></p>
							</c>
							<c ca="center">
								<p>H<sub>0</sub></p>
							</c>
							<c ca="center">
								<p>H<sub>5</sub></p>
							</c>
							<c ca="center">
								<p>H<sub>6</sub></p>
							</c>
						</r>
						<r>
							<c cspan="6">
								<hr/>
							</c>
						</r>
						<r>
							<c ca="left">
								<p>Temperature (&#176;C)</p>
							</c>
							<c ca="center">
								<p>35.2</p>
							</c>
							<c ca="center">
								<p>36.8</p>
							</c>
							<c ca="center">
								<p>40.2</p>
							</c>
							<c ca="center">
								<p>38.5</p>
							</c>
							<c ca="center">
								<p>38.5</p>
							</c>
						</r>
						<r>
							<c ca="left">
								<p>MAP (mmHg)</p>
							</c>
							<c ca="center">
								<p>65</p>
							</c>
							<c ca="center">
								<p>68</p>
							</c>
							<c ca="center">
								<p>55</p>
							</c>
							<c ca="center">
								<p>99</p>
							</c>
							<c ca="center">
								<p>97</p>
							</c>
						</r>
						<r>
							<c ca="left">
								<p>Heart rate (beats/min)</p>
							</c>
							<c ca="center">
								<p>65</p>
							</c>
							<c ca="center">
								<p>74</p>
							</c>
							<c ca="center">
								<p>117</p>
							</c>
							<c ca="center">
								<p>113</p>
							</c>
							<c ca="center">
								<p>111</p>
							</c>
						</r>
						<r>
							<c ca="left">
								<p>SpO<sub>2 </sub>(%)</p>
							</c>
							<c ca="center">
								<p>100</p>
							</c>
							<c ca="center">
								<p>100</p>
							</c>
							<c ca="center">
								<p>97</p>
							</c>
							<c ca="center">
								<p>96</p>
							</c>
							<c ca="center">
								<p>97</p>
							</c>
						</r>
						<r>
							<c ca="left">
								<p>Haemoglobin (g/l)</p>
							</c>
							<c ca="center">
								<p>11.0</p>
							</c>
							<c ca="center">
								<p>11.1</p>
							</c>
							<c ca="center">
								<p>13.6</p>
							</c>
							<c ca="center">
								<p>13.0</p>
							</c>
							<c ca="center">
								<p>13.0</p>
							</c>
						</r>
						<r>
							<c ca="left">
								<p>Serum lactate (mEq/l)</p>
							</c>
							<c ca="center">
								<p>3</p>
							</c>
							<c ca="center">
								<p>2</p>
							</c>
							<c ca="center">
								<p>10.3</p>
							</c>
							<c ca="center">
								<p>6.6</p>
							</c>
							<c ca="center">
								<p>6.2</p>
							</c>
						</r>
						<r>
							<c ca="left">
								<p>Cardiac index (l/min per m<sup>2</sup>)</p>
							</c>
							<c ca="center">
								<p>2.1</p>
							</c>
							<c ca="center">
								<p>2.3</p>
							</c>
							<c ca="center">
								<p>4.1</p>
							</c>
							<c ca="center">
								<p>6.5</p>
							</c>
							<c ca="center">
								<p>6.4</p>
							</c>
						</r>
						<r>
							<c ca="left">
								<p>SvO<sub>2 </sub>(%)</p>
							</c>
							<c ca="center">
								<p>65</p>
							</c>
							<c ca="center">
								<p>68</p>
							</c>
							<c ca="center">
								<p>75</p>
							</c>
							<c ca="center">
								<p>76</p>
							</c>
							<c ca="center">
								<p>75</p>
							</c>
						</r>
						<r>
							<c ca="left">
								<p><sup>o</sup>VO<sub>2 </sub>(mL/min per m<sup>2</sup>)</p>
							</c>
							<c ca="center">
								<p>88</p>
							</c>
							<c ca="center">
								<p>119</p>
							</c>
							<c ca="center">
								<p>178</p>
							</c>
							<c ca="center">
								<p>240</p>
							</c>
							<c ca="center">
								<p>237</p>
							</c>
						</r>
					</tblbdy>
					<tblfn>
						<p>H, delay in hours; ICU, intensive care unit; MAP, mean arterial pressure; SvO<sub>2</sub>, mixed venous oxygen saturation; <sup>o</sup>VO<sub>2</sub>, observed oxygen consumption.</p>
					</tblfn>
				</tbl>
				<p>The clinician on duty disregards the SvO<sub>2 </sub>threshold and concluded that the haemodynamic status was adequate to the patient's needs and no specific treatment was given. Two hours later (Table <tblr tid="T1">1</tblr>), a decrease in lactate serum value, normalization in SvO<sub>2 </sub>and a calculated <sup>o</sup>VO<sub>2 </sub>= basal VO<sub>2 </sub>demonstrate that metabolic needs were probably covered.</p>
				<p>In this case, a rough interpretation of SvO<sub>2 </sub>below 70% as an indicator of insufficient CO as compared with needs would have led to an unjustified increase in CO. An SvO<sub>2 </sub>below 70% can be normal in elderly patients, especially if haemoglobin level is low, as is frequently observed postoperatively.</p>
			</sec>
			<sec>
				<st>
					<p>Example 2</p>
				</st>
				<p>Patient 2, requiring sedation and mechanical ventilation, was admitted to an ICU with a history of sudden shock and hyperkinetic state (Table <tblr tid="T1">1</tblr>). Was VO<sub>2 </sub>adequate to needs? There is agreement between the clinical signs of shock with elevated lactate level and a calculated <sup>o</sup>VO<sub>2 </sub>below the needed value (216 ml/min per m<sup>2</sup>) according to basal VO<sub>2 </sub>fora 24-year-old man (152 ml/min per m<sup>2</sup>) corrected for the high temperature. In contrast, the SvO<sub>2 </sub>value, higher than normal values, suggests that CO and oxygen flow are adequate.</p>
				<p>Once again, the clinician on duty disregards the SvO<sub>2 </sub>threshold and concluded that the haemodynamic status was inadequate for the patient's needs. A resuscitation regimen combining cooling, fluid optimization, and dobutamine and noradrenaline (norepinephrine) was instituted in addition to antibiotics. CO increased, SvO<sub>2 </sub>remained stable (Table <tblr tid="T1">1</tblr>) and calculated <sup>o</sup>VO<sub>2 </sub>increased over its needed value, whereas lactate serum decreased, suggesting that metabolic needs were covered.</p>
				<p>In this case, an interpretation of the SvO<sub>2 </sub>above 70% as an indicator that the hyperkinetic state was adequate to needs would have led to insufficient resuscitation. SvO<sub>2 </sub>can be above 70% in pathological states, for instance involving severe impairment in tissue oxygen diffusion.</p>
			</sec>
		</sec>
		<sec>
			<st>
				<p>Practical implications</p>
			</st>
			<p>The rationale for incorporating the VO<sub>2</sub>/DO<sub>2 </sub>relationship into clinical management strategies is supported by several studies in which most of the limiting factors listed above were avoided <abbrgrp><abbr bid="B13">13</abbr><abbr bid="B14">14</abbr></abbrgrp>. In contrast, the chances of survival are very small in patients whose DO<sub>2 </sub>and VO<sub>2 </sub>fail to increase with treatment, despite evidence of an oxygen deficit <abbrgrp><abbr bid="B13">13</abbr><abbr bid="B14">14</abbr></abbrgrp>. Thus, reaching the critical DO<sub>2 </sub>and ensuring that VO<sub>2 </sub>needs are met are crucial objectives, even though these two variables are calculated or intuitively estimated. To increase the likelihood of identifying clinical benefits related to bedside VO<sub>2 </sub>guided therapy, we suggest a number of practical guidelines. As stated above, computer assistance may be helpful in harmonizing the diagnostic reasoning processes of different clinicians for different patients <abbrgrp><abbr bid="B2">2</abbr><abbr bid="B35">35</abbr></abbrgrp>.</p>
			<sec>
				<st>
					<p>Early detection of shock states</p>
				</st>
				<p>Shock responds better to haemodynamic resuscitation in the early stages <abbrgrp><abbr bid="B43">43</abbr></abbrgrp>. Although the final objective is to provide sufficient oxygen to each cell, there is some evidence that rapidly achieving a sufficient total body VO<sub>2 </sub>is a prerequisite. Late-stage shock is a far more complex situation that involves not only the macrocirculation and microcirculation but also cell metabolism and the consequences of cell necrosis, which cannot be corrected by haemodynamic resuscitation alone.</p>
			</sec>
			<sec>
				<st>
					<p>Matching oxygen consumption to needs is the first objective</p>
				</st>
				<p>In most situations, targeting a clinical improvement, a decrease in lactate level, or a pre-established value for CO or SvO<sub>2</sub>, or both, is an acceptable and intuitive means of achieving adequate VO<sub>2</sub>. In complex situations, by plotting VO<sub>2</sub>/DO<sub>2 </sub>over time during a DO<sub>2 </sub>challenge, the critical DO<sub>2 </sub>value can be evaluated rapidly by identifying the inflection point on the curve, and resuscitation efforts can then be limited to what is necessary. Because the critical DO<sub>2 </sub>value can be determined visually with a 95% confidence interval of 20%, it is reasonable to limit DO<sub>2 </sub>to its observed critical value +20%. When lactate remains high despite evidence that a VO<sub>2 </sub>plateau has been reached, increasing DO<sub>2 </sub>further does not seem to add benefit <abbrgrp><abbr bid="B13">13</abbr><abbr bid="B14">14</abbr></abbrgrp>. Continuous efforts to decrease oxygen demand and to improve the microcirculation may be more appropriate <abbrgrp><abbr bid="B47">47</abbr></abbrgrp>. Combined analysis of the VO<sub>2</sub>/DO<sub>2 </sub>and VO<sub>2</sub>/time relationships provides the most useful approach, because the effects of mathematical coupling of errors and the theoretical limitations resulting from DO<sub>2 </sub>variability in the regression line derivations are minimized. A mild up-sloping of the VO<sub>2 </sub>plateau (slope &lt;10%) should not be confused with oxygen dependency. When necessary, the critical DO<sub>2 </sub>point can be determined more accurately using the method developed by John-Alder and coworkers <abbrgrp><abbr bid="B48">48</abbr></abbrgrp>.</p>
			</sec>
			<sec>
				<st>
					<p>To reach this objective, the best compromise must be identified, mostly based on metabolic cost</p>
				</st>
				<p>Hyperthermia, acute respiratory failure and/or pain all increase VO<sub>2 </sub>needs sharply. In contrast, cooling, sedation and mechanical ventilation often produce a 50% decrease in VO<sub>2 </sub>needs. The latter has exactly the same favourable effect as doubling the CO or doubling the EO<sub>2</sub>. Improving EO<sub>2 </sub>must be always considered, although this rarely produces a rapid increase in VO<sub>2</sub>. Treating infection, excessive sedation, or excessive water retention, for example, may increase EO<sub>2 </sub><abbrgrp><abbr bid="B43">43</abbr></abbrgrp>. When the only possibility is to increase DO<sub>2</sub>, clinicians must choose among various agents that presumably differ in their caloric effects. Arterial vasodilatation improves DO<sub>2 </sub>and decreases myocardial oxygen requirements. In contrast, inotropic agents and vasoconstrictors have major caloric effects. Whatever the method used, a metabolic price must be paid for improving VO<sub>2 </sub>and DO<sub>2 </sub>up to critical values. This metabolic price (a part of VO<sub>2 </sub>needs) must also be limited to what is strictly necessary.</p>
			</sec>
		</sec>
		<sec>
			<st>
				<p>Conclusion</p>
			</st>
			<p>Matching the VO<sub>2 </sub>and <sup>n</sup>VO<sub>2 </sub>is a crucial objective in critically ill patients, and must take into account the specific situation of the patient and its pathological limitations. Achieving this objective requires one to decrease oxygen needs first, to improve EO<sub>2 </sub>when possible and then to improve DO<sub>2</sub>. In most situations, targeting a clinical improvement, a decrease in lactate level, or a pre-established value for CO, SaO<sub>2</sub>, or SvO<sub>2 </sub>(or all of these) is an acceptable and intuitive means of achieving an adequate VO<sub>2</sub>. However, intuitive evaluation of the needed value for each variable in each specific case requires considerable expertise, considering all available variables, and may be subject to error.</p>
			<p>In complex situations, by plotting VO<sub>2</sub>/DO<sub>2 </sub>over time during a DO<sub>2 </sub>challenge, the critical DO<sub>2 </sub>value can be rapidly identified as the inflection point on the curve, and resuscitation efforts can then be limited to what is necessary. Whatever the method used, a metabolic price must be paid for improving VO<sub>2 </sub>and DO<sub>2 </sub>to the critical values, and must be limited to what is strictly necessary. Thus, the more complex the critically ill presentation, the greater the number of global haemodynamic variables that are needed.</p>
			<p>Flow monitoring is of major interest in terms of stabilizing the macrocirculation. A stabilized macrocirculation is a global pre-requisite, and must be achieved before one looks at the local microcirculation.</p>
			<p>
				<it>Although we do not have direct evidence of any clinical benefits from invasive hemodynamic monitoring, we believe that more intensive monitoring (invasive or non-invasive) is needed to ensure the safety of acutely ill patients, otherwise we would not have ICUs.</it>
			</p>
			<p>Bellomo and Uchino <abbrgrp><abbr bid="B49">49</abbr></abbrgrp></p>
		</sec>
		<sec>
			<st>
				<p>Abbreviations</p>
			</st>
			<p>CO = cardiac output; DaO<sub>2 </sub>= arterial oxygen delivery; DO<sub>2 </sub>= oxygen delivery; EO<sub>2 </sub>= oxygen extraction ratio; ICU = intensive care unit; PAC = pulmonary artery catheter; SvO<sub>2 </sub>= mixed venous oxygen saturation; VO<sub>2 </sub>= oxygen consumption.</p>
		</sec>
		<sec>
			<st>
				<p>Competing interests</p>
			</st>
			<p>PS is a consultant for Edwards Lifesciences. This manuscript was written from a slide presentation as part of a European PAC course promoted by Edwards Lifesciences.</p>
		</sec>
	</bdy>
	<bm>
		<ack>
			<sec>
				<st>
					<p>Acknowledgements</p>
				</st>
				<p>The authors thank Professor Alexandre Mebazza for his critical review of the manuscript.</p>
			</sec>
		</ack>
		<refgrp>
			<bibl id="B1">
				<title>
					<p>Critical care in Europe</p>
				</title>
				<aug>
					<au>
						<snm>Vincent</snm>
						<fnm>JL</fnm>
					</au>
					<au>
						<snm>Thijs</snm>
						<fnm>L</fnm>
					</au>
					<au>
						<snm>Cerny</snm>
						<fnm>V</fnm>
					</au>
				</aug>
				<source>Crit Care Clin</source>
				<pubdate>1997</pubdate>
				<volume>13</volume>
				<fpage>245</fpage>
				<lpage>254</lpage>
				<xrefbib>
					<pubidlist>
						<pubid idtype="doi">10.1016/S0749-0704(05)70307-9</pubid>
						<pubid idtype="pmpid">9107505</pubid>
					</pubidlist>
				</xrefbib>
			</bibl>
			<bibl id="B2">
				<title>
					<p>Value of elementary, calculated and modeled hemodynamic variables</p>
				</title>
				<aug>
					<au>
						<snm>Squara</snm>
						<fnm>P</fnm>
					</au>
					<au>
						<snm>Journois</snm>
						<fnm>D</fnm>
					</au>
					<au>
						<snm>Formela</snm>
						<fnm>F</fnm>
					</au>
					<au>
						<snm>Dhainaut</snm>
						<fnm>J</fnm>
					</au>
					<au>
						<snm>Sollet</snm>
						<fnm>JP</fnm>
					</au>
					<au>
						<snm>Bleichner</snm>
						<fnm>G</fnm>
					</au>
				</aug>
				<source>J Crit Care</source>
				<pubdate>1994</pubdate>
				<volume>9</volume>
				<fpage>223</fpage>
				<lpage>235</lpage>
				<xrefbib>
					<pubidlist>
						<pubid idtype="doi">10.1016/0883-9441(94)90002-7</pubid>
						<pubid idtype="pmpid">7889133</pubid>
					</pubidlist>
				</xrefbib>
			</bibl>
			<bibl id="B3">
				<title>
					<p>The oxygen delivery/consumption controversy. Approaches to management of the critically ill</p>
				</title>
				<aug>
					<au>
						<snm>Russell</snm>
						<fnm>JA</fnm>
					</au>
					<au>
						<snm>Phang</snm>
						<fnm>PT</fnm>
					</au>
				</aug>
				<source>Am J Respir Crit Care Med</source>
				<pubdate>1994</pubdate>
				<volume>149</volume>
				<fpage>533</fpage>
				<lpage>537</lpage>
				<xrefbib>
					<pubid idtype="pmpid">8306058</pubid>
				</xrefbib>
			</bibl>
			<bibl id="B4">
				<title>
					<p>Matching total body oxygen consumption and delivery: a crucial objective?</p>
				</title>
				<aug>
					<au>
						<snm>Squara</snm>
						<fnm>P</fnm>
					</au>
				</aug>
				<source>Intensive Care Med</source>
				<pubdate>2004</pubdate>
				<volume>30</volume>
				<fpage>2170</fpage>
				<lpage>2179</lpage>
				<xrefbib>
					<pubidlist>
						<pubid idtype="doi">10.1007/s00134-004-2449-4</pubid>
						<pubid idtype="pmpid">15448891</pubid>
					</pubidlist>
				</xrefbib>
			</bibl>
			<bibl id="B5">
				<title>
					<p>Assessment of three methods to reduce the influence of mathematical coupling on oxygen consumption and delivery relationships</p>
				</title>
				<aug>
					<au>
						<snm>Granton</snm>
						<fnm>JT</fnm>
					</au>
					<au>
						<snm>Walley</snm>
						<fnm>KR</fnm>
					</au>
					<au>
						<snm>Phang</snm>
						<fnm>PT</fnm>
					</au>
					<au>
						<snm>Russell</snm>
						<fnm>JA</fnm>
					</au>
					<au>
						<snm>Lichtenstein</snm>
						<fnm>S</fnm>
					</au>
				</aug>
				<source>Chest</source>
				<pubdate>1998</pubdate>
				<volume>113</volume>
				<fpage>1347</fpage>
				<lpage>1355</lpage>
				<xrefbib>
					<pubid idtype="pmpid">9596318</pubid>
				</xrefbib>
			</bibl>
			<bibl id="B6">
				<title>
					<p>Significance of pathologic oxygen supply dependency in critically ill patients: comparison between measured and calculated methods</p>
				</title>
				<aug>
					<au>
						<snm>Hanique</snm>
						<fnm>G</fnm>
					</au>
					<au>
						<snm>Dugernier</snm>
						<fnm>T</fnm>
					</au>
					<au>
						<snm>Laterre</snm>
						<fnm>PF</fnm>
					</au>
					<au>
						<snm>Dougnac</snm>
						<fnm>A</fnm>
					</au>
					<au>
						<snm>Roeseler</snm>
						<fnm>J</fnm>
					</au>
					<au>
						<snm>Reynaert</snm>
						<fnm>MS</fnm>
					</au>
				</aug>
				<source>Intensive Care Med</source>
				<pubdate>1994</pubdate>
				<volume>20</volume>
				<fpage>12</fpage>
				<lpage>18</lpage>
				<xrefbib>
					<pubidlist>
						<pubid idtype="doi">10.1007/BF02425048</pubid>
						<pubid idtype="pmpid">8163752</pubid>
					</pubidlist>
				</xrefbib>
			</bibl>
			<bibl id="B7">
				<title>
					<p>Blood lactate levels are superior to oxygen-derived variables in predicting outcome in human septic shock</p>
				</title>
				<aug>
					<au>
						<snm>Bakker</snm>
						<fnm>J</fnm>
					</au>
					<au>
						<snm>Coffernils</snm>
						<fnm>M</fnm>
					</au>
					<au>
						<snm>Leon</snm>
						<fnm>M</fnm>
					</au>
					<au>
						<snm>Gris</snm>
						<fnm>P</fnm>
					</au>
					<au>
						<snm>Vincent</snm>
						<fnm>JL</fnm>
					</au>
				</aug>
				<source>Chest</source>
				<pubdate>1991</pubdate>
				<volume>99</volume>
				<fpage>956</fpage>
				<lpage>962</lpage>
				<xrefbib>
					<pubid idtype="pmpid">2009802</pubid>
				</xrefbib>
			</bibl>
			<bibl id="B8">
				<title>
					<p>Lactic acidosis</p>
				</title>
				<aug>
					<au>
						<snm>De Backer</snm>
						<fnm>D</fnm>
					</au>
				</aug>
				<source>Intensive Care Med</source>
				<pubdate>2003</pubdate>
				<volume>29</volume>
				<fpage>699</fpage>
				<lpage>702</lpage>
				<xrefbib>
					<pubid idtype="pmpid">12682722</pubid>
				</xrefbib>
			</bibl>
			<bibl id="B9">
				<title>
					<p>Serial blood lactate levels can predict the development of multiple organ failure following septic shock</p>
				</title>
				<aug>
					<au>
						<snm>Bakker</snm>
						<fnm>J</fnm>
					</au>
					<au>
						<snm>Gris</snm>
						<fnm>P</fnm>
					</au>
					<au>
						<snm>Coffernils</snm>
						<fnm>M</fnm>
					</au>
					<au>
						<snm>Kahn</snm>
						<fnm>RJ</fnm>
					</au>
					<au>
						<snm>Vincent</snm>
						<fnm>JL</fnm>
					</au>
				</aug>
				<source>Am J Surg</source>
				<pubdate>1996</pubdate>
				<volume>171</volume>
				<fpage>221</fpage>
				<lpage>226</lpage>
				<xrefbib>
					<pubidlist>
						<pubid idtype="doi">10.1016/S0002-9610(97)89552-9</pubid>
						<pubid idtype="pmpid">8619454</pubid>
					</pubidlist>
				</xrefbib>
			</bibl>
			<bibl id="B10">
				<title>
					<p>Comparison of oxygen consumption measurements: indirect calorimetry versus the reversed Fick method</p>
				</title>
				<aug>
					<au>
						<snm>Smithies</snm>
						<fnm>MN</fnm>
					</au>
					<au>
						<snm>Royston</snm>
						<fnm>B</fnm>
					</au>
					<au>
						<snm>Makita</snm>
						<fnm>K</fnm>
					</au>
					<au>
						<snm>Konieczko</snm>
						<fnm>K</fnm>
					</au>
					<au>
						<snm>Nunn</snm>
						<fnm>JF</fnm>
					</au>
				</aug>
				<source>Crit Care Med</source>
				<pubdate>1991</pubdate>
				<volume>19</volume>
				<fpage>1401</fpage>
				<lpage>1406</lpage>
				<xrefbib>
					<pubidlist>
						<pubid idtype="doi">10.1097/00003246-199111000-00017</pubid>
						<pubid idtype="pmpid">1935161</pubid>
					</pubidlist>
				</xrefbib>
			</bibl>
			<bibl id="B11">
				<title>
					<p>The effect of fluid loading, blood transfusion, and catecholamine infusion on oxygen delivery and consumption in patients with sepsis</p>
				</title>
				<aug>
					<au>
						<snm>Gilbert</snm>
						<fnm>EM</fnm>
					</au>
					<au>
						<snm>Haupt</snm>
						<fnm>MT</fnm>
					</au>
					<au>
						<snm>Mandanas</snm>
						<fnm>RY</fnm>
					</au>
					<au>
						<snm>Huaringa</snm>
						<fnm>AJ</fnm>
					</au>
					<au>
						<snm>Carlson</snm>
						<fnm>RW</fnm>
					</au>
				</aug>
				<source>Am Rev Respir Dis</source>
				<pubdate>1986</pubdate>
				<volume>134</volume>
				<fpage>873</fpage>
				<lpage>878</lpage>
				<xrefbib>
					<pubid idtype="pmpid">3777684</pubid>
				</xrefbib>
			</bibl>
			<bibl id="B12">
				<title>
					<p>Oxygen uptake/supply dependency. Effects of short-term dobutamine infusion</p>
				</title>
				<aug>
					<au>
						<snm>Vincent</snm>
						<fnm>JL</fnm>
					</au>
					<au>
						<snm>Roman</snm>
						<fnm>A</fnm>
					</au>
					<au>
						<snm>De Backer</snm>
						<fnm>D</fnm>
					</au>
					<au>
						<snm>Kahn</snm>
						<fnm>RJ</fnm>
					</au>
				</aug>
				<source>Am Rev Respir Dis</source>
				<pubdate>1990</pubdate>
				<volume>142</volume>
				<fpage>2</fpage>
				<lpage>7</lpage>
				<xrefbib>
					<pubid idtype="pmpid">2368971</pubid>
				</xrefbib>
			</bibl>
			<bibl id="B13">
				<title>
					<p>A prospective study of the use of a dobutamine stress test to identify outcome in patients with sepsis, severe sepsis, or septic shock</p>
				</title>
				<aug>
					<au>
						<snm>Rhodes</snm>
						<fnm>A</fnm>
					</au>
					<au>
						<snm>Lamb</snm>
						<fnm>FJ</fnm>
					</au>
					<au>
						<snm>Malagon</snm>
						<fnm>I</fnm>
					</au>
					<au>
						<snm>Newman</snm>
						<fnm>PJ</fnm>
					</au>
					<au>
						<snm>Grounds</snm>
						<fnm>RM</fnm>
					</au>
					<au>
						<snm>Bennett</snm>
						<fnm>ED</fnm>
					</au>
				</aug>
				<source>Crit Care Med</source>
				<pubdate>1999</pubdate>
				<volume>27</volume>
				<fpage>2361</fpage>
				<lpage>2366</lpage>
				<xrefbib>
					<pubidlist>
						<pubid idtype="doi">10.1097/00003246-199911000-00007</pubid>
						<pubid idtype="pmpid">10579249</pubid>
					</pubidlist>
				</xrefbib>
			</bibl>
			<bibl id="B14">
				<title>
					<p>Prognostic value of the dobutamine test in patients with sepsis syndrome and normal lactate values: a prospective, multicenter study</p>
				</title>
				<aug>
					<au>
						<snm>Vallet</snm>
						<fnm>B</fnm>
					</au>
					<au>
						<snm>Chopin</snm>
						<fnm>C</fnm>
					</au>
					<au>
						<snm>Curtis</snm>
						<fnm>SE</fnm>
					</au>
					<au>
						<snm>Dupuis</snm>
						<fnm>BA</fnm>
					</au>
					<au>
						<snm>Fourrier</snm>
						<fnm>F</fnm>
					</au>
					<au>
						<snm>Mehdaoui</snm>
						<fnm>H</fnm>
					</au>
					<au>
						<snm>LeRoy</snm>
						<fnm>B</fnm>
					</au>
					<au>
						<snm>Rime</snm>
						<fnm>A</fnm>
					</au>
					<au>
						<snm>Santre</snm>
						<fnm>C</fnm>
					</au>
					<au>
						<snm>Herbecq</snm>
						<fnm>P</fnm>
					</au>
					<etal/>
				</aug>
				<source>Crit Care Med</source>
				<pubdate>1993</pubdate>
				<volume>21</volume>
				<fpage>1868</fpage>
				<lpage>1875</lpage>
				<xrefbib>
					<pubidlist>
						<pubid idtype="doi">10.1097/00003246-199312000-00014</pubid>
						<pubid idtype="pmpid">8252892</pubid>
					</pubidlist>
				</xrefbib>
			</bibl>
			<bibl id="B15">
				<title>
					<p>The effects of vasodilation with prostacyclin on oxygen delivery and uptake in critically ill patients</p>
				</title>
				<aug>
					<au>
						<snm>Bihari</snm>
						<fnm>D</fnm>
					</au>
					<au>
						<snm>Smithies</snm>
						<fnm>M</fnm>
					</au>
					<au>
						<snm>Gimson</snm>
						<fnm>A</fnm>
					</au>
					<au>
						<snm>Tinker</snm>
						<fnm>J</fnm>
					</au>
				</aug>
				<source>N Engl J Med</source>
				<pubdate>1987</pubdate>
				<volume>317</volume>
				<fpage>397</fpage>
				<lpage>403</lpage>
				<xrefbib>
					<pubid idtype="pmpid">3302704</pubid>
				</xrefbib>
			</bibl>
			<bibl id="B16">
				<title>
					<p>Relationship between O2 delivery and O2 consumption in the adult respiratory distress syndrome</p>
				</title>
				<aug>
					<au>
						<snm>Mohsenifar</snm>
						<fnm>Z</fnm>
					</au>
					<au>
						<snm>Goldbach</snm>
						<fnm>P</fnm>
					</au>
					<au>
						<snm>Tashkin</snm>
						<fnm>DP</fnm>
					</au>
					<au>
						<snm>Campisi</snm>
						<fnm>DJ</fnm>
					</au>
				</aug>
				<source>Chest</source>
				<pubdate>1983</pubdate>
				<volume>84</volume>
				<fpage>267</fpage>
				<lpage>271</lpage>
				<xrefbib>
					<pubid idtype="pmpid">6349945</pubid>
				</xrefbib>
			</bibl>
			<bibl id="B17">
				<title>
					<p>Skeletal muscle PO2 during hypoxemia and isovolemic anemia</p>
				</title>
				<aug>
					<au>
						<snm>Gutierrez</snm>
						<fnm>G</fnm>
					</au>
					<au>
						<snm>Marini</snm>
						<fnm>C</fnm>
					</au>
					<au>
						<snm>Acero</snm>
						<fnm>AL</fnm>
					</au>
					<au>
						<snm>Lund</snm>
						<fnm>N</fnm>
					</au>
				</aug>
				<source>J Appl Physiol</source>
				<pubdate>1990</pubdate>
				<volume>68</volume>
				<fpage>2047</fpage>
				<lpage>2053</lpage>
				<xrefbib>
					<pubid idtype="pmpid">2361907</pubid>
				</xrefbib>
			</bibl>
			<bibl id="B18">
				<title>
					<p>Pathological supply dependence of O2 uptake during bacteremia in dogs</p>
				</title>
				<aug>
					<au>
						<snm>Nelson</snm>
						<fnm>DP</fnm>
					</au>
					<au>
						<snm>Beyer</snm>
						<fnm>C</fnm>
					</au>
					<au>
						<snm>Samsel</snm>
						<fnm>RW</fnm>
					</au>
					<au>
						<snm>Wood</snm>
						<fnm>LD</fnm>
					</au>
					<au>
						<snm>Schumacker</snm>
						<fnm>PT</fnm>
					</au>
				</aug>
				<source>J Appl Physiol</source>
				<pubdate>1987</pubdate>
				<volume>63</volume>
				<fpage>1487</fpage>
				<lpage>1492</lpage>
				<xrefbib>
					<pubid idtype="pmpid">3693185</pubid>
				</xrefbib>
			</bibl>
			<bibl id="B19">
				<title>
					<p>Effects of dobutamine on oxygen consumption in septic patients. Direct versus indirect determinations</p>
				</title>
				<aug>
					<au>
						<snm>De Backer</snm>
						<fnm>D</fnm>
					</au>
					<au>
						<snm>Moraine</snm>
						<fnm>JJ</fnm>
					</au>
					<au>
						<snm>Berre</snm>
						<fnm>J</fnm>
					</au>
					<au>
						<snm>Kahn</snm>
						<fnm>RJ</fnm>
					</au>
					<au>
						<snm>Vincent</snm>
						<fnm>JL</fnm>
					</au>
				</aug>
				<source>Am J Respir Crit Care Med</source>
				<pubdate>1994</pubdate>
				<volume>150</volume>
				<fpage>95</fpage>
				<lpage>100</lpage>
				<xrefbib>
					<pubid idtype="pmpid">8025780</pubid>
				</xrefbib>
			</bibl>
			<bibl id="B20">
				<title>
					<p>Renal effects of amino acid infusion in cardiac surgery</p>
				</title>
				<aug>
					<au>
						<snm>Jeppsson</snm>
						<fnm>A</fnm>
					</au>
					<au>
						<snm>Ekroth</snm>
						<fnm>R</fnm>
					</au>
					<au>
						<snm>Friberg</snm>
						<fnm>P</fnm>
					</au>
					<au>
						<snm>Kirno</snm>
						<fnm>K</fnm>
					</au>
					<au>
						<snm>Milocco</snm>
						<fnm>I</fnm>
					</au>
					<au>
						<snm>Nilsson</snm>
						<fnm>F</fnm>
					</au>
					<au>
						<snm>Svensson</snm>
						<fnm>S</fnm>
					</au>
				</aug>
				<source>J Cardiothorac Vasc Anesth</source>
				<pubdate>2000</pubdate>
				<volume>14</volume>
				<fpage>51</fpage>
				<lpage>55</lpage>
				<xrefbib>
					<pubidlist>
						<pubid idtype="doi">10.1016/S1053-0770(00)90056-9</pubid>
						<pubid idtype="pmpid">10698393</pubid>
					</pubidlist>
				</xrefbib>
			</bibl>
			<bibl id="B21">
				<title>
					<p>Effects of histamine, acetylcholine, and norepinephrine on gastric vascular resistance</p>
				</title>
				<aug>
					<au>
						<snm>Jacobson</snm>
						<fnm>E</fnm>
					</au>
				</aug>
				<source>Am J Physiol</source>
				<pubdate>1963</pubdate>
				<volume>204</volume>
				<fpage>1013</fpage>
				<lpage>1017</lpage>
				<xrefbib>
					<pubid idtype="pmpid">13964350</pubid>
				</xrefbib>
			</bibl>
			<bibl id="B22">
				<title>
					<p>Oxygen consumption and blood flow in resting mamalians skeletal muscles</p>
				</title>
				<aug>
					<au>
						<snm>Duran</snm>
						<fnm>W</fnm>
					</au>
					<au>
						<snm>Renkin</snm>
						<fnm>E</fnm>
					</au>
				</aug>
				<source>Am J Physiol</source>
				<pubdate>1974</pubdate>
				<volume>226</volume>
				<fpage>173</fpage>
				<lpage>177</lpage>
				<xrefbib>
					<pubid idtype="pmpid">4809879</pubid>
				</xrefbib>
			</bibl>
			<bibl id="B23">
				<title>
					<p>Oxygen-derived free radicals in post ischemic tissue injury</p>
				</title>
				<aug>
					<au>
						<snm>McCord</snm>
						<fnm>J</fnm>
					</au>
				</aug>
				<source>N Engl J Med</source>
				<pubdate>1985</pubdate>
				<volume>312</volume>
				<fpage>159</fpage>
				<lpage>161</lpage>
				<xrefbib>
					<pubid idtype="pmpid">2981404</pubid>
				</xrefbib>
			</bibl>
			<bibl id="B24">
				<title>
					<p>Oxygen conformance of cellular respiration in hepatocytes</p>
				</title>
				<aug>
					<au>
						<snm>Schumacker</snm>
						<fnm>PT</fnm>
					</au>
					<au>
						<snm>Chandel</snm>
						<fnm>N</fnm>
					</au>
					<au>
						<snm>Agusti</snm>
						<fnm>AG</fnm>
					</au>
				</aug>
				<source>Am J Physiol</source>
				<pubdate>1993</pubdate>
				<volume>265</volume>
				<fpage>L395</fpage>
				<lpage>L402</lpage>
				<xrefbib>
					<pubid idtype="pmpid">8238374</pubid>
				</xrefbib>
			</bibl>
			<bibl id="B25">
				<title>
					<p>Oxygen delivery and uptake relationships in patients with aortic stenosis</p>
				</title>
				<aug>
					<au>
						<snm>Schumacker</snm>
						<fnm>PT</fnm>
					</au>
					<au>
						<snm>Soble</snm>
						<fnm>JS</fnm>
					</au>
					<au>
						<snm>Feldman</snm>
						<fnm>T</fnm>
					</au>
				</aug>
				<source>Am J Respir Crit Care Med</source>
				<pubdate>1994</pubdate>
				<volume>149</volume>
				<fpage>1123</fpage>
				<lpage>1131</lpage>
				<xrefbib>
					<pubid idtype="pmpid">8173751</pubid>
				</xrefbib>
			</bibl>
			<bibl id="B26">
				<title>
					<p>Persistence of supply dependency of oxygen uptake at high levels of delivery in adult respiratory distress syndrome</p>
				</title>
				<aug>
					<au>
						<snm>Clarke</snm>
						<fnm>C</fnm>
					</au>
					<au>
						<snm>Edwards</snm>
						<fnm>JD</fnm>
					</au>
					<au>
						<snm>Nightingale</snm>
						<fnm>P</fnm>
					</au>
					<au>
						<snm>Mortimer</snm>
						<fnm>AJ</fnm>
					</au>
					<au>
						<snm>Morris</snm>
						<fnm>J</fnm>
					</au>
				</aug>
				<source>Crit Care Med</source>
				<pubdate>1991</pubdate>
				<volume>19</volume>
				<fpage>497</fpage>
				<lpage>502</lpage>
				<xrefbib>
					<pubidlist>
						<pubid idtype="doi">10.1097/00003246-199104000-00007</pubid>
						<pubid idtype="pmpid">2019134</pubid>
					</pubidlist>
				</xrefbib>
			</bibl>
			<bibl id="B27">
				<title>
					<p>Oxygen consumption is linearly related to O2 supply in critically ill patients</p>
				</title>
				<aug>
					<au>
						<snm>Gutierrez</snm>
						<fnm>G</fnm>
					</au>
					<au>
						<snm>Pohil</snm>
						<fnm>RJ</fnm>
					</au>
				</aug>
				<source>J Crit Care</source>
				<pubdate>1986</pubdate>
				<volume>1</volume>
				<fpage>45</fpage>
				<lpage>53</lpage>
				<xrefbib>
					<pubid idtype="doi">10.1016/S0883-9441(86)80116-2</pubid>
				</xrefbib>
			</bibl>
			<bibl id="B28">
				<title>
					<p>Use of survivors' cardiorespiratory values as therapeutic goals in septic shock</p>
				</title>
				<aug>
					<au>
						<snm>Edwards</snm>
						<fnm>J</fnm>
					</au>
					<au>
						<snm>Brown</snm>
						<fnm>G</fnm>
					</au>
					<au>
						<snm>Nightingale</snm>
						<fnm>P</fnm>
					</au>
					<au>
						<snm>Slater</snm>
						<fnm>RM</fnm>
					</au>
					<au>
						<snm>Faragher</snm>
						<fnm>EB</fnm>
					</au>
				</aug>
				<source>Crit Care Med</source>
				<pubdate>1989</pubdate>
				<volume>17</volume>
				<fpage>1098</fpage>
				<lpage>1103</lpage>
				<xrefbib>
					<pubid idtype="pmpid">2791588</pubid>
				</xrefbib>
			</bibl>
			<bibl id="B29">
				<title>
					<p>Prospective trial of supranormal values of survivors as therapeutic goals in high-risk surgical patients</p>
				</title>
				<aug>
					<au>
						<snm>Shoemaker</snm>
						<fnm>W</fnm>
					</au>
					<au>
						<snm>Appel</snm>
						<fnm>P</fnm>
					</au>
					<au>
						<snm>Kram</snm>
						<fnm>H</fnm>
					</au>
					<au>
						<snm>Waxman</snm>
						<fnm>K</fnm>
					</au>
					<au>
						<snm>Lee</snm>
						<fnm>T</fnm>
					</au>
				</aug>
				<source>Chest</source>
				<pubdate>1988</pubdate>
				<volume>94</volume>
				<fpage>1176</fpage>
				<lpage>1186</lpage>
				<xrefbib>
					<pubid idtype="pmpid">3191758</pubid>
				</xrefbib>
			</bibl>
			<bibl id="B30">
				<title>
					<p>A trial of goal-oriented hemodynamic therapy in critically ill patients. SvO2 Collaborative Group</p>
				</title>
				<aug>
					<au>
						<snm>Gattinoni</snm>
						<fnm>L</fnm>
					</au>
					<au>
						<snm>Brazzi</snm>
						<fnm>L</fnm>
					</au>
					<au>
						<snm>Pelosi</snm>
						<fnm>P</fnm>
					</au>
					<au>
						<snm>Latini</snm>
						<fnm>R</fnm>
					</au>
					<au>
						<snm>Tognoni</snm>
						<fnm>G</fnm>
					</au>
					<au>
						<snm>Pesenti</snm>
						<fnm>A</fnm>
					</au>
					<au>
						<snm>Fumagalli</snm>
						<fnm>R</fnm>
					</au>
				</aug>
				<source>N Engl J Med</source>
				<pubdate>1995</pubdate>
				<volume>333</volume>
				<fpage>1025</fpage>
				<lpage>1032</lpage>
				<xrefbib>
					<pubidlist>
						<pubid idtype="doi">10.1056/NEJM199510193331601</pubid>
						<pubid idtype="pmpid">7675044</pubid>
					</pubidlist>
				</xrefbib>
			</bibl>
			<bibl id="B31">
				<title>
					<p>Elevation of systemic oxygen delivery in the treatment of critically ill patients</p>
				</title>
				<aug>
					<au>
						<snm>Hayes</snm>
						<fnm>MA</fnm>
					</au>
					<au>
						<snm>Timmings</snm>
						<fnm>AC</fnm>
					</au>
					<au>
						<snm>Yau</snm>
						<fnm>EH</fnm>
					</au>
					<au>
						<snm>Palazzo</snm>
						<fnm>M</fnm>
					</au>
					<au>
						<snm>Hinds</snm>
						<fnm>CJ</fnm>
					</au>
					<au>
						<snm>Watson</snm>
						<fnm>D</fnm>
					</au>
				</aug>
				<source>N Engl J Med</source>
				<pubdate>1994</pubdate>
				<volume>330</volume>
				<fpage>1717</fpage>
				<lpage>1722</lpage>
				<xrefbib>
					<pubidlist>
						<pubid idtype="doi">10.1056/NEJM199406163302404</pubid>
						<pubid idtype="pmpid">7993413</pubid>
					</pubidlist>
				</xrefbib>
			</bibl>
			<bibl id="B32">
				<title>
					<p>Lack of oxygen supply dependency in patients with severe sepsis. A study of oxygen delivery increased by military antishock trouser and dobutamine</p>
				</title>
				<aug>
					<au>
						<snm>Mira</snm>
						<fnm>J</fnm>
					</au>
					<au>
						<snm>Fabre</snm>
						<fnm>J</fnm>
					</au>
					<au>
						<snm>Baigorr</snm>
						<fnm>IF</fnm>
					</au>
					<au>
						<snm>Coste</snm>
						<fnm>J</fnm>
					</au>
					<au>
						<snm>Annat</snm>
						<fnm>G</fnm>
					</au>
					<au>
						<snm>Artigas</snm>
						<fnm>A</fnm>
					</au>
					<au>
						<snm>Nitenberg</snm>
						<fnm>G</fnm>
					</au>
					<au>
						<snm>Dhainaut</snm>
						<fnm>J</fnm>
					</au>
				</aug>
				<source>Chest</source>
				<pubdate>1994</pubdate>
				<volume>106</volume>
				<fpage>1524</fpage>
				<lpage>1531</lpage>
				<xrefbib>
					<pubid idtype="pmpid">7956414</pubid>
				</xrefbib>
			</bibl>
			<bibl id="B33">
				<title>
					<p>Intensive care physicians' insufficient knowledge of right heart catheterization at the bedside: time to act?</p>
				</title>
				<aug>
					<au>
						<snm>Gnaegi</snm>
						<fnm>A</fnm>
					</au>
					<au>
						<snm>Feihl</snm>
						<fnm>F</fnm>
					</au>
					<au>
						<snm>Perret</snm>
						<fnm>C</fnm>
					</au>
				</aug>
				<source>Crit Care Med</source>
				<pubdate>1997</pubdate>
				<volume>25</volume>
				<fpage>213</fpage>
				<lpage>220</lpage>
				<xrefbib>
					<pubidlist>
						<pubid idtype="doi">10.1097/00003246-199702000-00003</pubid>
						<pubid idtype="pmpid">9034253</pubid>
					</pubidlist>
				</xrefbib>
			</bibl>
			<bibl id="B34">
				<title>
					<p>Pulmonary artery catheter: does the problem lie in the users?</p>
				</title>
				<aug>
					<au>
						<snm>Squara</snm>
						<fnm>P</fnm>
					</au>
					<au>
						<snm>Bennett</snm>
						<fnm>D</fnm>
					</au>
					<au>
						<snm>Perret</snm>
						<fnm>C</fnm>
					</au>
				</aug>
				<source>Chest</source>
				<pubdate>2002</pubdate>
				<volume>121</volume>
				<fpage>2009</fpage>
				<lpage>2015</lpage>
				<xrefbib>
					<pubidlist>
						<pubid idtype="doi">10.1378/chest.121.6.2009</pubid>
						<pubid idtype="pmpid">12065369</pubid>
					</pubidlist>
				</xrefbib>
			</bibl>
			<bibl id="B35">
				<title>
					<p>Computer assistance for hemodynamic evaluation</p>
				</title>
				<aug>
					<au>
						<snm>Squara</snm>
						<fnm>P</fnm>
					</au>
					<au>
						<snm>Dhainaut</snm>
						<fnm>J</fnm>
					</au>
					<au>
						<snm>Lamy</snm>
						<fnm>M</fnm>
					</au>
					<au>
						<snm>Perret</snm>
						<fnm>C</fnm>
					</au>
					<au>
						<snm>Larbuisson</snm>
						<fnm>R</fnm>
					</au>
					<au>
						<snm>Poli</snm>
						<fnm>S</fnm>
					</au>
					<au>
						<snm>Armaganidis</snm>
						<fnm>A</fnm>
					</au>
					<au>
						<snm>de Gournay</snm>
						<fnm>J</fnm>
					</au>
					<au>
						<snm>Bleichner</snm>
						<fnm>G</fnm>
					</au>
				</aug>
				<source>J Crit Care</source>
				<pubdate>1989</pubdate>
				<volume>4</volume>
				<fpage>273</fpage>
				<lpage>282</lpage>
				<xrefbib>
					<pubid idtype="doi">10.1016/0883-9441(89)90067-1</pubid>
				</xrefbib>
			</bibl>
			<bibl id="B36">
				<title>
					<p>Hemodyn homepage</p>
				</title>
				<url>http://www.hemodyn.com</url>
			</bibl>
			<bibl id="B37">
				<title>
					<p>A randomized clinical trial of the effect of deliberate perioperative increase of oxygen delivery on mortality in high-risk surgical patients</p>
				</title>
				<aug>
					<au>
						<snm>Boyd</snm>
						<fnm>O</fnm>
					</au>
					<au>
						<snm>Grounds</snm>
						<fnm>RM</fnm>
					</au>
					<au>
						<snm>Bennett</snm>
						<fnm>ED</fnm>
					</au>
				</aug>
				<source>JAMA</source>
				<pubdate>1993</pubdate>
				<volume>270</volume>
				<fpage>2699</fpage>
				<lpage>2707</lpage>
				<xrefbib>
					<pubidlist>
						<pubid idtype="doi">10.1001/jama.270.22.2699</pubid>
						<pubid idtype="pmpid">7907668</pubid>
					</pubidlist>
				</xrefbib>
			</bibl>
			<bibl id="B38">
				<title>
					<p>Meta-analysis of hemodynamic optimization in high-risk patients</p>
				</title>
				<aug>
					<au>
						<snm>Kern</snm>
						<fnm>JW</fnm>
					</au>
					<au>
						<snm>Shoemaker</snm>
						<fnm>WC</fnm>
					</au>
				</aug>
				<source>Crit Care Med</source>
				<pubdate>2002</pubdate>
				<volume>30</volume>
				<fpage>1686</fpage>
				<lpage>1692</lpage>
				<xrefbib>
					<pubidlist>
						<pubid idtype="doi">10.1097/00003246-200208000-00002</pubid>
						<pubid idtype="pmpid">12163777</pubid>
					</pubidlist>
				</xrefbib>
			</bibl>
			<bibl id="B39">
				<title>
					<p>Hemodynamic and oxygen transport variables in cardiogenic shock secondary to acute myocardial infarction, and response to treatment</p>
				</title>
				<aug>
					<au>
						<snm>Creamer</snm>
						<fnm>JE</fnm>
					</au>
					<au>
						<snm>Edwards</snm>
						<fnm>JD</fnm>
					</au>
					<au>
						<snm>Nightingale</snm>
						<fnm>P</fnm>
					</au>
				</aug>
				<source>Am J Cardiol</source>
				<pubdate>1990</pubdate>
				<volume>65</volume>
				<fpage>1297</fpage>
				<lpage>1300</lpage>
				<xrefbib>
					<pubidlist>
						<pubid idtype="doi">10.1016/0002-9149(90)91316-X</pubid>
						<pubid idtype="pmpid">2343817</pubid>
					</pubidlist>
				</xrefbib>
			</bibl>
			<bibl id="B40">
				<title>
					<p>Use of continuous noninvasive measurement of oxygen consumption in patients with adult respiratory distress syndrome following shock of various etiologies</p>
				</title>
				<aug>
					<au>
						<snm>Hankeln</snm>
						<fnm>KB</fnm>
					</au>
					<au>
						<snm>Gronemeyer</snm>
						<fnm>R</fnm>
					</au>
					<au>
						<snm>Held</snm>
						<fnm>A</fnm>
					</au>
					<au>
						<snm>Bohmert</snm>
						<fnm>F</fnm>
					</au>
				</aug>
				<source>Crit Care Med</source>
				<pubdate>1991</pubdate>
				<volume>19</volume>
				<fpage>642</fpage>
				<lpage>649</lpage>
				<xrefbib>
					<pubidlist>
						<pubid idtype="doi">10.1097/00003246-199105000-00010</pubid>
						<pubid idtype="pmpid">2026026</pubid>
					</pubidlist>
				</xrefbib>
			</bibl>
			<bibl id="B41">
				<title>
					<p>A multicenter evaluation of a new continuous cardiac output pulmonary artery catheter system</p>
				</title>
				<aug>
					<au>
						<snm>Mihm</snm>
						<fnm>FG</fnm>
					</au>
					<au>
						<snm>Gettinger</snm>
						<fnm>A</fnm>
					</au>
					<au>
						<snm>Hanson</snm>
						<fnm>CW</fnm>
						<suf>3rd</suf>
					</au>
					<au>
						<snm>Gilbert</snm>
						<fnm>HC</fnm>
					</au>
					<au>
						<snm>Stover</snm>
						<fnm>EP</fnm>
					</au>
					<au>
						<snm>Vender</snm>
						<fnm>JS</fnm>
					</au>
					<au>
						<snm>Beerle</snm>
						<fnm>B</fnm>
					</au>
					<au>
						<snm>Haddow</snm>
						<fnm>G</fnm>
					</au>
				</aug>
				<source>Crit Care Med</source>
				<pubdate>1998</pubdate>
				<volume>26</volume>
				<fpage>1346</fpage>
				<lpage>1350</lpage>
				<xrefbib>
					<pubidlist>
						<pubid idtype="doi">10.1097/00003246-199808000-00018</pubid>
						<pubid idtype="pmpid">9710092</pubid>
					</pubidlist>
				</xrefbib>
			</bibl>
			<bibl id="B42">
				<title>
					<p>Accuracy assessment for three fiberoptic pulmonary artery catheters for SvO2 monitoring</p>
				</title>
				<aug>
					<au>
						<snm>Armaganidis</snm>
						<fnm>A</fnm>
					</au>
					<au>
						<snm>Dhainaut</snm>
						<fnm>JF</fnm>
					</au>
					<au>
						<snm>Billard</snm>
						<fnm>JL</fnm>
					</au>
					<au>
						<snm>Klouche</snm>
						<fnm>K</fnm>
					</au>
					<au>
						<snm>Mira</snm>
						<fnm>JP</fnm>
					</au>
					<au>
						<snm>Brunet</snm>
						<fnm>F</fnm>
					</au>
					<au>
						<snm>Dinh-Xuan</snm>
						<fnm>AT</fnm>
					</au>
					<au>
						<snm>Dall'Ava-Santucci</snm>
						<fnm>J</fnm>
					</au>
				</aug>
				<source>Intensive Care Med</source>
				<pubdate>1994</pubdate>
				<volume>20</volume>
				<fpage>484</fpage>
				<lpage>488</lpage>
				<xrefbib>
					<pubidlist>
						<pubid idtype="doi">10.1007/BF01711900</pubid>
						<pubid idtype="pmpid">7995864</pubid>
					</pubidlist>
				</xrefbib>
			</bibl>
			<bibl id="B43">
				<title>
					<p>Early goal-directed therapy in the treatment of severe sepsis and septic shock</p>
				</title>
				<aug>
					<au>
						<snm>Rivers</snm>
						<fnm>E</fnm>
					</au>
					<au>
						<snm>Nguyen</snm>
						<fnm>B</fnm>
					</au>
					<au>
						<snm>Havstad</snm>
						<fnm>S</fnm>
					</au>
					<au>
						<snm>Ressler</snm>
						<fnm>J</fnm>
					</au>
					<au>
						<snm>Muzzin</snm>
						<fnm>A</fnm>
					</au>
					<au>
						<snm>Knoblich</snm>
						<fnm>B</fnm>
					</au>
					<au>
						<snm>Peterson</snm>
						<fnm>E</fnm>
					</au>
					<au>
						<snm>Tomlanovich</snm>
						<fnm>M</fnm>
					</au>
				</aug>
				<source>N Engl J Med</source>
				<pubdate>2001</pubdate>
				<volume>345</volume>
				<fpage>1368</fpage>
				<lpage>1377</lpage>
				<xrefbib>
					<pubidlist>
						<pubid idtype="doi">10.1056/NEJMoa010307</pubid>
						<pubid idtype="pmpid">11794169</pubid>
					</pubidlist>
				</xrefbib>
			</bibl>
			<bibl id="B44">
				<title>
					<p>Central venous oxygen saturation during hypovolaemic shock in humans</p>
				</title>
				<aug>
					<au>
						<snm>Madsen</snm>
						<fnm>P</fnm>
					</au>
					<au>
						<snm>Iversen</snm>
						<fnm>H</fnm>
					</au>
					<au>
						<snm>Secher</snm>
						<fnm>NH</fnm>
					</au>
				</aug>
				<source>Scand J Clin Lab Invest</source>
				<pubdate>1993</pubdate>
				<volume>53</volume>
				<fpage>67</fpage>
				<lpage>72</lpage>
				<xrefbib>
					<pubid idtype="pmpid">8451602</pubid>
				</xrefbib>
			</bibl>
			<bibl id="B45">
				<title>
					<p>A maximal central venous oxygen saturation (SvO2max) for the surgical patient</p>
				</title>
				<aug>
					<au>
						<snm>Jenstrup</snm>
						<fnm>M</fnm>
					</au>
					<au>
						<snm>Ejlersen</snm>
						<fnm>E</fnm>
					</au>
					<au>
						<snm>Mogensen</snm>
						<fnm>T</fnm>
					</au>
					<au>
						<snm>Secher</snm>
						<fnm>NH</fnm>
					</au>
				</aug>
				<source>Acta Anaesthesiol Scand Suppl</source>
				<pubdate>1995</pubdate>
				<volume>107</volume>
				<fpage>29</fpage>
				<lpage>32</lpage>
				<xrefbib>
					<pubid idtype="pmpid">8599293</pubid>
				</xrefbib>
			</bibl>
			<bibl id="B46">
				<title>
					<p>Mixed venous oxygen saturation in critically ill septic shock patients. The role of defined events</p>
				</title>
				<aug>
					<au>
						<snm>Krafft</snm>
						<fnm>P</fnm>
					</au>
					<au>
						<snm>Steltzer</snm>
						<fnm>H</fnm>
					</au>
					<au>
						<snm>Hiesmayr</snm>
						<fnm>M</fnm>
					</au>
					<au>
						<snm>Klimscha</snm>
						<fnm>W</fnm>
					</au>
					<au>
						<snm>Hammerle</snm>
						<fnm>AF</fnm>
					</au>
				</aug>
				<source>Chest</source>
				<pubdate>1993</pubdate>
				<volume>103</volume>
				<fpage>900</fpage>
				<lpage>906</lpage>
				<xrefbib>
					<pubid idtype="pmpid">8449089</pubid>
				</xrefbib>
			</bibl>
			<bibl id="B47">
				<title>
					<p>Nitroglycerin in septic shock after intravascular volume resuscitation</p>
				</title>
				<aug>
					<au>
						<snm>Spronk</snm>
						<fnm>PE</fnm>
					</au>
					<au>
						<snm>Ince</snm>
						<fnm>C</fnm>
					</au>
					<au>
						<snm>Gardien</snm>
						<fnm>MJ</fnm>
					</au>
					<au>
						<snm>Mathura</snm>
						<fnm>KR</fnm>
					</au>
					<au>
						<snm>Oudemans-van Straaten</snm>
						<fnm>HM</fnm>
					</au>
					<au>
						<snm>Zandstra</snm>
						<fnm>DF</fnm>
					</au>
				</aug>
				<source>Lancet</source>
				<pubdate>2002</pubdate>
				<volume>360</volume>
				<fpage>1395</fpage>
				<lpage>1396</lpage>
				<xrefbib>
					<pubidlist>
						<pubid idtype="doi">10.1016/S0140-6736(02)11393-6</pubid>
						<pubid idtype="pmpid">12423989</pubid>
					</pubidlist>
				</xrefbib>
			</bibl>
			<bibl id="B48">
				<title>
					<p>Thermal dependence of endurance and locomotory energetics in a lizard</p>
				</title>
				<aug>
					<au>
						<snm>John-Alder</snm>
						<fnm>HB</fnm>
					</au>
					<au>
						<snm>Bennett</snm>
						<fnm>AF</fnm>
					</au>
				</aug>
				<source>Am J Physiol</source>
				<pubdate>1981</pubdate>
				<volume>241</volume>
				<fpage>R342</fpage>
				<lpage>R349</lpage>
				<xrefbib>
					<pubid idtype="pmpid">7304779</pubid>
				</xrefbib>
			</bibl>
			<bibl id="B49">
				<title>
					<p>Cardiovascular monitoring tools: use and misuse</p>
				</title>
				<aug>
					<au>
						<snm>Bellomo</snm>
						<fnm>R</fnm>
					</au>
					<au>
						<snm>Uchino</snm>
						<fnm>S</fnm>
					</au>
				</aug>
				<source>Curr Opin Crit Care</source>
				<pubdate>2003</pubdate>
				<volume>9</volume>
				<fpage>225</fpage>
				<lpage>229</lpage>
				<xrefbib>
					<pubidlist>
						<pubid idtype="doi">10.1097/00075198-200306000-00010</pubid>
						<pubid idtype="pmpid">12771675</pubid>
					</pubidlist>
				</xrefbib>
			</bibl>
		</refgrp>
	</bm>
</art>
